Abstract: An authentication system reads at random or in a predetermined sequence a few, typically 3 to 5, unique product identifiers inside the package to decide whether the content is authentic or not. This cross-referencing check does not require a database connection to a central repository or database. The unique product identifiers are produced when pharmaceutical products are manufactured using embossing, for example, and a product sequence is defined by physical attributes and locations of pharmaceutical products in the packaging, the product sequence then being encrypted and used to mark the packaging of the one or more packaging levels with a coding. The coding is used to authenticate the products in the packaging downstream in the supply chain.

Abstract: An authentication system reads at random or in a predetermined sequence a few, typically 3 to 5, unique product identifiers inside the package to decide whether the content is authentic or not. This cross-referencing check does not require a database connection to a central repository or database. The unique product identifiers are produced when pharmaceutical products are manufactured using embossing, for example, and a product sequence is defined by physical attributes and locations of pharmaceutical products in the packaging, the product sequence then being encrypted and used to mark the packaging of the one or more packaging levels with a coding. The coding is used to authenticate the products in the packaging downstream in the supply chain.

Abstract: The present invention relates to a method for the authentication of dosage forms such as tablets, in particular pharmaceutical tablets, by reading, i.e. detecting, code structure from the tablet, reading additional information from the package or on an information sheet, and then comparing the readings to verify authenticity. The code structure may be randomized on a plurality of tablets disposed in identifiable locations in a shared package such that the detected code structures define a unique digital signature for the package of tablets.

Abstract: Pharmaceutical tablets and dosage forms are stored in a blister pack or other type of packaging which include additional anti-counterfeiting measures that are difficult to simulate and easy to reveal with a laser pointer. The blister pack is embossed with a hidden security feature including hidden information that is revealed only when a laser beam is directed through the packaging to be deflected at the hidden security feature. The hidden security feature may also accompany other covert and/or overt security features, including multi-level hologram features embossed into the blister pack at the same time as the hidden security feature.

Abstract: The present invention relates to a method for the authentication of dosage forms such as tablets, in particular pharmaceutical tablets, by reading, i.e. detecting, code structure from the tablet, reading additional information from the package or on an information sheet, and then comparing the readings to verify authenticity. The code structure may be randomized on a plurality of tablets disposed in identifiable locations in a shared package such that the detected code structures define a unique digital signature for the package of tablets.